Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Eutro ( EUTO ) -- Ignore unavailable to you. Want to Upgrade?

To: Robert Rice who wrote (5732)	5/18/1998 12:18:00 AM
From: Whitetigr	Read Replies (2) \| Respond to of 12043

I now fully understand, anyone that does not agree with you is labeled insulting, now I am rude and mocking too for not agreeing with you and showing how you are trying to inflate the stock price. For what reason so you can sell then buy more when it dips and blame it on someone else??? Your #'s don't add up. You say grossly undervalued and I ask what book value is since you have determined it is grossly undervalued. We have already established that what we haven't rcvd is not yet income and even if we include it. The 600,000 from RF does not specify over what period of time, a year or three since they will be consulting in ongoing operations. Freedom Medical 300,000 if it is ever paid to Eutro. Now on these 2 any shares that will be distributed is already valued in there so don't count that twice. What are you figuring your multiple on? Looking at what you have there you are doing your multiple on Eutro's gross income. That sure is not a P/E multiple and don't try to tell me that by calculating a multiple the way you did it there is an indication of value because it's not. To use your method of analysis, here is one you would find to be grossly undervalued. ZE it has sales of 1.7Billion / 67.5Mil shares outstanding X your even more concervative multiple of 14 = $352.00 so doing your math the share price should be in that area. Well book value of this company is -1.33 and share price is around 3.50 Look for yourself if you don't believe it. You state Bio pays all the bills and is now apparently turning a profit. Ok but Eutro itself still has bills to pay. Since you still can not show book value and we have no profit margin or profit that we can base a multiple on I can not agree that it is grossly undervalued. You talk about what the company is worth but your way of figuring multiples is not the standard way the multiple is calculated. You are correct this is not some kids game and it's real money and right now I'm wondering how many people you tried to convince this stock should have a 14Mil dollar valuation because of the way you figure your P/E multiple. Next time you want to be insulting to someone that has a different opinion to express than you do it would be in your best interest to have your numbers right. I think your intentions here are quite obvious now.